Hepatocellular carcinoma in long-term oral contraceptive use

Liver

Volumn 16, Issue 6, 1996, Pages 372-376

  Isabel Fiel, M ^a   Min, Albert ^b   Gerber, Michael A ^c   Faire, Bridget ^b   Schwartz, Myron ^b   Thung, Swan N ^a,d  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Liver tumor; Oral contraceptive steroids

Indexed keywords

MESTRANOL PLUS NORETHISTERONE; ORAL CONTRACEPTIVE AGENT;

ADULT; AFRICA; ARTICLE; ASIA; CASE REPORT; CHRONIC HEPATITIS; DISEASE CARRIER; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LONG TERM CARE; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; UNITED STATES;

EID: 12644280804     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1996.tb00764.x     Document Type: Article

References (39)

1. NEUBERGER J, FORMAN D, DOLL R, WILLIAMS R. Oral contraceptives and hepatocellular carcinoma. Br Med J 1986: 292: 1355-1357.
2. FORMAN D, VINCENT T J, DOLL R. Cancer of the liver and the use of oral contraceptives. Br Med J 1986: 292: 1357-1361.
3. LA VECCHIA C, NEGRI E, PARAZZINI F. Oral contraceptives and primary liver cancer. Br J Cancer 1989: 59: 460-461.
4. Davis M, Portmann B, Searle M, Wright R, Williams R. Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br Med J 1975: 4: 496-498.
5. FERRELL L. Hepatocellular carcinoma arising in a focus of multilobular adenoma. A case report. Am J Surg Pathol 1993: 17: 525-539.
6. GYORFFY E J, BEDFELDR J E, BLACK W C. Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use. Ann Intern Med 1989: 110: 489-490.
7. MAYS E T, CHRISTOPHERSON W M, MAHR M M, WILLIAMS H C. Hepatic changes in young women ingesting contraceptive steroids. Hepatic hemorrhage and primary hepatic tumors. JAMA 1976: 235: 730-732.
8. NEUBERGER J, NUNNERLEY H B, DAVIS M, PORTMANN B, LAWS J W, WILLIAMS R. Oral contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosis. Lancer 1980: 1: 273-276.
9. HORVATH E, KOVACS K, ROSS R C. Ultrastructural findings in a well differentiated hepatoma. Digestion 1972: 7: 74-82.
10. THUNG S N, GERBER M A. Development of malignancy in benign tumors of the liver. In: Tabor E, Di Bisceglie AM. Purcell RH, eds. Etiology, pathology and treatment of hepatocellular carcinoma in North America. Houston, London, Tokyo: Gulf Publishing Co., 1991: 209-215.
11. COE J E, ISHAK K G, ROSS M J. Estrogen induction of hepatocellular carcinoma in Armenian hamsters. Hepatology 1990: 11: 570-577.
12. YAGER J D, ZURLO L, NI N. Sex hormones and tumor promotion in liver. Proc Soc Exp Biol Med 1991: 198: 677-674.
13. PORTER L E, VAN THIEL D H, EAGON P K. Estrogens and progestins as tumor inducers. Sem Liver Dis 1987: 7: 24-31.
14. HASAN F, JEFFERS L J, DE MEDINA M, et al. Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990: 12: 589-591.
15. FARINATI F, FAGINOLI S, De MARIA N. et al. Anti-HCV positive hepatocellular carcinoma in cirrhosis. J Hepatol 1992: 14: 183-187.
16. YU M C, TONG MJ, COURSAGET P, ROSS R K, GOVINDARAJAN S, HENDERSON B E. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 1990: 82: 1038-1041.
17. NALPAS B, DRISS F, HAMELIN B, HOUSSET C, Brechot C, BERTHELOT P. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol 1991: 12: 70-74.
18. KEW M C, POPPER H. Relationship between hepatocellular carcinoma and cirrhosis. Sem Liver Dis 1984: 4: 136-146.
19. TABOR E A. Hepatocellular carcinoma: possible etiologies in patients without serologic evidence of hepatitis B virus infection. J Med Virol 1989: 27: 1-6.
20. LAMPERTICO P, MALTER J S, COLOMBO M, GERBER M A. Detection of hepatitis B virus (HBV) DNA in formalin-fixed, paraffin-embedded liver tissue by the polymerase chain reaction (PCR). Am J Pathol 1991: 88: 1058-1060.
21. GERBER M A, SHIEH C Y S, SHIM K S, et al. Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma. Am J Pathol 1992; 141: 1271-1277.
22. LAI M-Y, CHEN P-J, YANG P-M, SHEU J-C, SUNG J-L, CHEN D-S. Identification and characterization of intrahepatic hepatitis B virus DNA in HBsAg-seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan. Hepatology 1990: 12: 575-581.
23. PATERLINI P, DRISS F, NALPAS B, et al. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: A study of a low-endemic area. Hepatology 1993: 117: 20-29.
24. ZAVITSANOS X, HATZAKIS A, KAKLAMANI E, et al. Association between hepatitis C virus and hepatocellular carcinoma using assays based on structural and non-structural hepatitis C virus peptides. Cancer Res 1992: 52: 5364-5357.
25. RUIZ J, SANGRO B, CUENDE J I, et al. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992: 16: 637-641.
26. SHEU J-C, HUANG G-T, SHIH L-N, et al. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 1992: 103: 1322-1327.
27. THUNG S N, GERBER M A. Precursor stage of hepatocellular neoplasm following long exposure to orally administered contraceptives. Hum Pathol 1981: 12: 472-475.
28. BAUM J K, HOLTZ F, BOOKSTEIN J T. KLEIN E W. Possible as-sociation between benign hepatomas and oral contraceptives. Lancet 1973: 2: 926-929.
29. EDMONDSON H A, HENDERSON B, BENTON B. Liver cell adenomas associated with use of oral contraceptives. N Engl J Med 1976: 294: 470-472.
30. CHRISTOPHERSON W M, MAYS E T. Liver tumors and contraceptive steroids: experience with the first hundred registry patients. J Natl Cancer Inst 1977: 58: 167-171.
31. VANA J, MURPHY G P, ARONOFF B L, BAKER H W. Primary liver tumors and oral contraceptives. JAMA 1977: 238: 2154-2158.
32. ROOKS J B, ORY H W, ISHAK K G. et al. The Cooperative Liver Tumor Study Group: Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979: 242: 644-648.
33. PALMER J R, ROSENBERG L, KAUFMAN D W, WARSHAUER M E, STOLLEY P, SHAPIRO S. Oral contraceptive use and liver cancer. Am J Epidemiol 1989: 130: 878-882.
34. THE WHO COLLABORATIVE STUDY OF NEOPLASIA AND STEROID CONTRACEPTIVES. Combined oral contraceptives and liver cancer. Int J Cancer 1989: 43: 254-25S.
35. TESLUK H, LAWRIE J. Hepatocellular adenoma: its transformation to carcinoma in a user of oral contraceptives. Arch Pathol Lab Med 1981: 105: 296-299.
36. WANLESS I R, MEDLINE A. Role of estrogens as promoters of hepatic neoplasia. Lab Invest 1982: 46: 313-320.
37. METZLER M, DEGEN C H. Sex hormones and neoplasia. Liver tumors in rodents. Arch Toxicol Suppl 1987: 10: 251-263.
38. KALAYCI C, JOHNSON P J, DAVIS S E, WILLIAMS R. Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver. J Hepatol 1991: 12: 54-59.
39. MAYS E T, CHRISTOPHERSON W M. Hepatic tumors induced by sex steroids. Sem Liver Dis 1984: 4: 147-157.